StonvexLoading…
StonvexStonvexStonvexCore line items from VNOM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $496.00M | $1.35B | $924.00M | $244.00M |
Operating Income | $253.00M | $-140.00M | $114.00M | $155.00M |
Net Income | $97.00M | $-68.00M | $35.00M | $75.00M |
EPS (Diluted) | $0.53 | $-0.48 | $0.25 | $0.62 |
Total Assets | $12.05B | $12.67B | $13.69B | Not available |
Total Liabilities | $1.68B | $2.31B | $2.75B | Not available |
Cash & Equivalents | $28.00M | $13.00M | $53.00M | $560.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 181.42M | 142.53M | 133.87M | 121.03M |